โรคที่เกิดจากการติดเชื้อไวรัส (Viral Diseases)

Viral – staphylococcal mastitis : Buddle BM, et al, “Protective effect of glucan against experimentally induced staphylococcal mastitis in ewes.” Vet Microbiol 16(1): 67-76, Jan 1988.

Viral Diseases: “The Biological activity of beta-glucans”; Minerva Medical; 100(3):237-245; Pub Med 19571787;  Jun 2009; Quote: “…Beta-glucans have studied for their hypocholesterolemic effects; these mechanisms include: reducing the intestinal absorption of cholesterol and bile acids by binding to glucans; shifting the liver from cholesterol syntheses to bile acid production; and fermentation by intestinal bacteria to short-chain fatty acids, which are absorbed and inhibit hepatic cholesterol syntheses. …beta-1,3-glucans improve the body’s immune system defense against foreign invaders by enhancing the ability of macrophages, neutrophils and natural killer cells to respond to and fight a wide range of challenges such as bacteria, viruses, fungi, and parasites. …there is renewed interest in the potential usefulness of beta-glucan as a radioprotective drug for chemotherapy, radiation therapy and nuclear emergencies, particularly because glucan can be used not only as a treatment, but also as a prophylactic [taken in advance for protection].”

Viral Diseases: Browder IW., Williams D., Pretus H., et al; “Beneficial Effect of Enhanced Macrophage Function in the Trauma Patients.” Ann. Surg.;  Vol 211: 605-613. Dept of Surg and Physiol, Tulane U Sch of Med, LA and Istituto Di Chirurgia D’Urgenza, U of Torino, Torino, Italy.* 1990. Quote: “Previous studies have demonstrated that glucan, a beta-1,3-linked glucopyranose polymer, isolated from the inner cell wall of Saccharomyces cerevisiae, is a potent  macrophage stimulant and is beneficial in the therapy of experimental bacterial, viral, and fungal diseases.“

Viral Infections: Jamas S, Easson D, Ostroff G: “Underivatilized aqueous soluble beta (1,3) glucan, composition and method of making same.” U.S. Patent Application 20020032170, March 14, 2002. Quote: The use of soluble and insoluble beta glucans alone or as vaccine adjuvants for viral and bacterial antigens has been shown in animal models to markedly increase resistance to a variety of bacterial, fungal, protozoan and viral infections.”

Viral Infections: Czop, Joyce K., “The Role of Beta.-Glucan Receptors on Blood and Tissue Leukocytes in Phagocytosis and Metabolic Activation”.  Pathology and Immunopathology Research; 5:286-296. Harvard Medical School. 1986. Quote: “…the presence of a particulate activator can rapidly initiate assembly and amplification of a host defense system involving humoral and cellular interactions with B-glucans. …Animals pretreated with purified glucan particles are subsequently more resistant to bacterial, viral, fungal, and protozoan challenge, reject antigenically incompatible grafts more rapidly and produce higher titers of serum antibodies to specific antigens.

Viral Infection: DiLuzio N.R.,”Immunopharmacology of glucan: a broad spectrum enhancer of host defense mechanisms,” Trends in Pharmacol. SCI., 4:344-347. Dept of Physiology, Tulane U, New Orleans, LA.* 1983. Quote: “The broad spectrum of immunopharmacological activities of glucan includes not only the modification of certain bacterial, fungal, viral and parasitic infections, but also inhibition of tumor growth.”

Viral Pathogens: Hunter K, Gault R, Jordan F; “Mode of Action of B-Glucan Immunopotentiators-Research Summary Release,” Department of Microbiology, University of Nevada School of Medicine, Jan 2001. Quote: “MG Glucan [micronized glucan insoluble particulate] has been shown to enhance the envelopment and digestion (phagocytosis) of pathogenic microorganisms [viral, bacterial, fungal, etc.] that cause infectious disease…Laboratory studies have revealed the new MG Glucan is significantly effective at activating Macrophages, and via the Macrophages, the entire immune cascade including T-Cells and B-Cells.”


 

Comments are closed.